Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
03/08/2012 | US20120058088 Resveratrol-Containing Compositions And Methods Of Use |
03/08/2012 | US20120058055 Gastrorententive oral high dose zinc preparations |
03/08/2012 | US20120058049 Cromolyn derivatives and related methods of imaging and treatment |
03/08/2012 | DE102010040233A1 Bicyclische Aza-Heterocyclen und ihre Verwendung Aza-bicyclic heterocycles and their use |
03/08/2012 | DE102010040187A1 Substituierte N-Phenethyl-triazolonacetamide und ihre Verwendung Substituted N-phenethyl-triazolonacetamide and their use |
03/08/2012 | CA2809911A1 Bicyclic aza heterocycles, and use thereof |
03/08/2012 | CA2809716A1 Substituted n-phenethyltriazoloneacetamides and use thereof |
03/08/2012 | CA2809568A1 Treatment of myocardial infarction using tgf - beta antagonists |
03/08/2012 | CA2809493A1 Peptide or peptide complex binding to .alpha.2 integrin and methods and uses involving the same |
03/08/2012 | CA2809112A1 Cyclic amide derivative |
03/07/2012 | EP2426135A1 Urea derivative having pi3k inhibitory activity |
03/07/2012 | EP2426126A1 Method for producing olmesartan medoxomil |
03/07/2012 | EP2426113A1 Carbinol compound having heterocyclic linker |
03/07/2012 | EP2426109A1 Novel kinase inhibitors |
03/07/2012 | EP2425841A1 Methods Employing and Compositions Containing Defined Oxidized Phospholipids for Prevention and Treatment of Atherosclerosis |
03/07/2012 | EP2425827A1 Transdermal preparation |
03/07/2012 | EP2424861A1 Indole-2-carboxamide derivative |
03/07/2012 | EP2424860A1 Heteroarylthiomethyl pyridine derivative |
03/07/2012 | EP2424857A1 Dual-action inhibitors and methods of using same |
03/07/2012 | EP2424854A2 Compositions and methods for treatment of cardiovascular disease |
03/07/2012 | EP2424545A1 Natural molecules extracted from bergamot tissues, extraction process and pharmaceutical use |
03/07/2012 | EP2424529A2 Novel therapeutic treatments using centhaquin |
03/07/2012 | EP2424524A1 Treatment or prophylaxis of proliferative conditions |
03/07/2012 | EP2424522A1 Composition for removing atheromatous plaque |
03/07/2012 | EP2424517A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists |
03/07/2012 | EP2424515A1 N omega-hydroxy-l-arginine derivatives for the treatment of diseases |
03/07/2012 | EP2424509A2 Fixed dose drug combination formulations |
03/07/2012 | EP1982986B1 Pyrrolopyridazinone compound as pde4 inhibitor |
03/07/2012 | EP1948155B1 Pharmaceutical compositions comprising droxidopa |
03/07/2012 | EP1638525B1 Inhalable formulations for treating pulmonary hypertension and methods of using same |
03/07/2012 | EP1519732B1 Use of vasopeptidase inhibitors in the treatment of nephropathy |
03/07/2012 | EP0885192B1 Dihydropyridine-, pyridine-, benzopyran- one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists |
03/07/2012 | CN202157038U 一种肝素生产中的原料前期处理装置 One kind of heparin pre-treatment of raw materials in the production of apparatus |
03/07/2012 | CN202157037U 一种肝素分离沉淀装置 One kind of precipitate was isolated by means of heparin |
03/07/2012 | CN1821242B Novel method for preparing dihydroxy acid HMG CoA reductase inhibitor |
03/07/2012 | CN102369205A Fused ring compound and use thereof |
03/07/2012 | CN102369200A Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof |
03/07/2012 | CN102369197A 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines used as adp receptor antagonists |
03/07/2012 | CN102369196A Azetidines as histamine h3 receptor antagonists |
03/07/2012 | CN102369190A Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency |
03/07/2012 | CN102369005A Production method for ubiquinone powder for use in preparations and product thereof |
03/07/2012 | CN102367257A Single-crystal crystal forms of clopidogrel hydrochloride and preparation method and application thereof |
03/07/2012 | CN102367243A Stable potassium sodium dehydroandroan drographolide succinate compound and pharmaceutical composition thereof |
03/07/2012 | CN102367227A Stable Levocarnitine compound and pharmaceutical composition thereof |
03/07/2012 | CN102366611A Traditional Chinese medicine lavipeditum composition for treating hypertension |
03/07/2012 | CN102366605A Traditional Chinese medicine preparation for treating hypertension and hyperlipidemia, and its preparation method |
03/07/2012 | CN102366601A Traditional Chinese medicine preparation for treating apoplexia, facial paralysis and hemiplegia |
03/07/2012 | CN102366600A Formula and method for treating liver channel and heart channel two-tissue combined diseases with traditional Chinese medicines |
03/07/2012 | CN102366572A Chinese herbal medicine for treating hemorrhoids |
03/07/2012 | CN102366556A Medicine for treating cerebral embolism sequela and preparation method thereof |
03/07/2012 | CN102366518A Method for ultrasonic assisted aqueous two-phase extraction of total dioscin |
03/07/2012 | CN102366505A Plaster for treating hypertension and preparation method thereof |
03/07/2012 | CN102366453A Traditional Chinese medicinal preparation for treating strokes and Bi syndromes |
03/07/2012 | CN102366451A Self-heated traditional Chinese medicine (TCM) emplastrum for improving stroke sequelae |
03/07/2012 | CN102366419A Application of rutin and derivative thereof in preparation of antihypoxic medicaments |
03/07/2012 | CN102366413A Application of glyceryl tributyrate in preparation of drug for treating cardiovascular disease |
03/07/2012 | CN102366412A Preparation method of tolvaptan tablet |
03/07/2012 | CN102366410A Argatroban liposome injection |
03/07/2012 | CN102366402A Scopolamine hydrobromide injection and production technology |
03/07/2012 | CN102366400A Betahistine hydrochloride injection and its production technology |
03/07/2012 | CN102048691B Breviscapin-containing oral cavity spraying agent and preparation method thereof |
03/07/2012 | CN101966172B New purpose of caffeic acid and derivatives thereof |
03/07/2012 | CN101836963B Medicinal application preparation for curing hypertension |
03/07/2012 | CN101744899B Traditional Chinese medicine paste for treating chemotherapy phlebitis vasospasm stage and preparation |
03/07/2012 | CN101716148B Tirofiban hydrochloride freeze-dried powder injection preparation and preparation method thereof |
03/07/2012 | CN101485670B Application of glucopyranoside compound in preparing medicament for improving hypertensive cerebrovascular remodeling |
03/07/2012 | CN101390986B Traditional Chinese medicine composition for cerebral thrombus and preparation method thereof |
03/07/2012 | CN101264227B Detection method of 'pingfeng shengmai' capsule |
03/07/2012 | CN101264066B Rutin osmotic pump preparations and preparation thereof |
03/07/2012 | CN101204438B Application of potentilla anseriana extractive on preparating anti-ischemic |
03/07/2012 | CN101084993B Medicinal composition containing dalbergia and storax, preparation method and preparation |
03/07/2012 | CN101084992B Medicinal composition containing safflower and ginseng, preparation method and preparation |
03/06/2012 | US8129545 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
03/06/2012 | US8129541 5-phenylthiazole derivatives and use as PI3 kinase inhibitors |
03/06/2012 | US8129407 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
03/06/2012 | US8129381 Caspase inhibitors and uses thereof |
03/06/2012 | US8129378 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer |
03/06/2012 | US8129373 Carbonyl compounds |
03/06/2012 | US8129370 Use of oxicam compounds |
03/06/2012 | US8129332 Reagents and methods for smooth muscle therapies |
03/06/2012 | US8129331 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT |
03/06/2012 | US8129144 Papilloma pseudovirus and preparation |
03/06/2012 | US8129112 Polymorphisms in the human CYP2D6 gene promoter region and their use in diagnostic and therapeutic applications |
03/06/2012 | US8128963 Methods for treating ischemic disorders using carbon monoxide |
03/06/2012 | CA2613041C Agent for improving insulin resistance |
03/06/2012 | CA2604017C Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives |
03/06/2012 | CA2530632C Inhalable formulations for treating pulmonary hypertension and methods of using same |
03/06/2012 | CA2486055C Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
03/06/2012 | CA2483707C Microparticles bearing cells and active substances |
03/06/2012 | CA2480666C Tnp-470 polymer conjugates and use thereof |
03/06/2012 | CA2476056C Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
03/06/2012 | CA2452881C Novel bicyclic and tricyclic cannabinoids |
03/06/2012 | CA2445664C Use of il-18 inhibitors for treating or preventing cns injuries |
03/06/2012 | CA2370697C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
03/01/2012 | WO2012027514A2 Compositions and methods for cardiac therapy |
03/01/2012 | WO2012027322A1 Oxadiazole inhibitors of leukotriene production |
03/01/2012 | WO2012027277A2 Compositions for reducing the deleterious effects of stress and aging |
03/01/2012 | WO2012027237A1 Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy |
03/01/2012 | WO2012026914A1 Methods and compositions for treating internal and external hemorrhoids |
03/01/2012 | WO2012026614A1 Composition suppressing matrix-metalloproteinase activity |